Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 288
Selected: 0
NCT IDTitle
NCT01323569Abuse Potential of Sativex
NCT05636111Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
NCT03954106A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
NCT02053272A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
NCT02332655Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
NCT00780182Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers
NCT04602936Solriamfetol in Binge Eating Disorder
NCT01599234A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis
NCT02221869A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
NCT02056782A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia
NCT04203498Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
NCT00590915Erwinase Master Treatment Protocol
NCT01426295Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital
NCT05642442A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease
NCT05391724Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects
NCT05629702ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
NCT02806895Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA
NCT02238925An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients
NCT05178316A Study of JZP150 in Adults With Posttraumatic Stress Disorder
NCT05091567A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
NCT01551524Phase I Study of mPEG-R-Crisantaspase Given IV
NCT03101241A Phase 2 RCT Study of CX-8998 for Essential Tremor
NCT00003966Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
NCT03339297An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)
NCT05392374Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
NCT02087306Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection
NCT02647190Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older
NCT00641186Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)
NCT00106860A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
NCT05169307CPX-351 Real-World Effectiveness and Safety Study
NCT04721691Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
NCT06182410Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma
NCT00710424A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy
NCT00389428Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.
NCT01696084Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
NCT03825796CPX-351 Plus Enasidenib for Relapsed AML
NCT00506974Enhancing Slow Wave Sleep With Sodium Oxybate
NCT00097708Experimental Medication For the Treatment of Generalized Anxiety Disorder
NCT00594256Sodium Oxybate in Schizophrenia With Insomnia
NCT01643408A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
NCT06143839VYxeoS Liposomal Italian Observational Study iN the Real Practice
NCT06113237Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
NCT01606137A Study of the Long-term Safety of Sativex Use
NCT05542407ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
NCT07156435Vyxeos® With Clofarabine for Pediatric AML
NCT04592159Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder
NCT02607891A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
NCT01898520A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years
NCT03878199Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
NCT04038437A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML